Newsroom

Sorted by: Latest

-

Uber Announces Date of First Quarter 2026 Results Conference Call

SAN FRANCISCO--(BUSINESS WIRE)--Uber Technologies, Inc. (NYSE: UBER) will hold its quarterly conference call to discuss its first quarter 2026 financial results on Wednesday, May 6th at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time). A live webcast of the conference call and earnings release materials can be found on Uber’s Investor Relations website at investor.uber.com. A replay of the conference call will be accessible for at least 90 days. Disclosure Information Uber uses and intends to co...
-

Hamilton Establishes Casualty Reinsurance Sidecar

PEMBROKE, Bermuda--(BUSINESS WIRE)--Hamilton Insurance Group, Ltd. (NYSE: HG) (“Hamilton” or the “Company”) today announced it has established a casualty reinsurance sidecar to provide dedicated underwriting capacity in support of the Company’s casualty reinsurance portfolio. This sidecar will provide reinsurance capital over a multi-year period, with ceded premium over the duration of the structure projected to be approximately $300 million. The investor capital and overall asset strategy will...
-

Teradyne to Announce First Quarter 2026 Results

NORTH READING, Mass.--(BUSINESS WIRE)--Teradyne, Inc. (NASDAQ: TER) will release financial results for the first quarter 2026 on Tuesday, April 28, 2026 at 4:30 p.m. Eastern Time (ET) or later. A conference call to discuss the first quarter results, along with management's business outlook, will follow at 8:30 a.m. ET, Wednesday, April 29, 2026. Interested investors should access the webcast at investors.teradyne.com/events-presentations at least five minutes before the call begins. Presentatio...
-

Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United Sta...
-

JetBlue Announces Webcast of First Quarter 2026 Earnings Conference Call

NEW YORK--(BUSINESS WIRE)--JetBlue Airways Corporation (Nasdaq: JBLU) announced today that it will hold its quarterly conference call to discuss first quarter 2026 financial results on April 28th, 2026 at 10:00 a.m. ET. A live, listen-only webcast of the call will be available on JetBlue's investor relations website at the following web address: http://investor.jetblue.com For those unable to listen to the live webcast, it will also be archived on JetBlue's investor relations website under 'Arc...
-

Concentra Chief Medical Officer Dr. Anderson to Retire After 33 Years

ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation’s largest provider of occupational health services by number of locations, today announced that Dr. John Anderson, executive vice president and Chief Medical Officer (CMO), will retire from Concentra at the end of the year. Dr. Anderson plans to advise the company as part of a consulting arrangement following his planned departure. The company has ini...
-

Ralliant Announces First Quarter 2026 Earnings Release and Conference Call Date

RALEIGH, N.C.--(BUSINESS WIRE)--Ralliant Corporation (“Ralliant” or the “Company”) (NYSE: RAL) will release earnings for the first quarter of 2026 before the opening of the New York Stock Exchange on Tuesday, May 12, 2026. The Company will host a conference call on Tuesday, May 12, 2026, at 8:30 a.m. ET, to discuss the results. The conference call can be accessed by dialing 877-407-8211 within the U.S. or +1 201-389-0902 outside the U.S. before 8:30 a.m. ET and notifying the operator that you a...
-

First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced that Cabaletta Bio Inc.’s (“Cabaletta Bio” or “Cabaletta”) (Nasdaq: CABA) investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) has been infused into the first two patients using drug product manufactured on Cellares' Cell Shuttle™ automated manufacturing platform. The administration of an autologous cell therapy, which met all release...
-

Equity Bancshares, Inc. First Quarter Results Highlighted by Record Revenue and An Expanding Franchise

WICHITA, Kan.--(BUSINESS WIRE)--Equity Bancshares, Inc. (NYSE: EQBK), (“Equity”, “the Company,” “we,” “us,” “our”), the Wichita-based holding company of Equity Bank, reported net income of $17.0 million or $0.80 per diluted share for the quarter ended March 31, 2026. Adjusting for pre-tax expenses associated with our merger, including provisioning for the acquired loan assets, with Frontier Holdings ("Frontier"), tax effected at 23%, net income was $26.3 million, or $1.23 per diluted share. “20...
-

MVB Financial Sets Date for First Quarter 2026 Earnings Release and Conference Call

FAIRMONT, W.Va.--(BUSINESS WIRE)--MVB Financial Corp. (“MVBF,” “MVB Financial,” or the “Company”) (Nasdaq: MVBF) announced today that it will release its first quarter 2026 financial results after market close on Wednesday, April 29, 2026. A webcast and conference call to discuss the results will be held on the same day at 5 p.m. Eastern Time. Webcast: A live webcast of the conference call will be available in the Events & Presentations section of the Company’s website at https://ir.mvbbank...